Form 4 for BIIB Biogen
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001127602-24-003440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-05 | 2024-02-01 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,828 | 5,292 | +53% | $0 |
| D | 2024-02-05 | 2024-02-02 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $245.93 | -634 | 4,097 | -13% | -$155.9K |
| D | 2024-02-05 | 2024-02-01 | BIIB | Singhal Priya | Head of Development | F - Tax | $247.83 | -561 | 4,731 | -11% | -$139.0K |
| D | 2024-02-05 | 2024-02-01 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -1,828 | 3,657 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 1,828 | $0.00 | 5,292.09 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-02 | S | D | 634 | $245.93 | 4,097.09 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-01 | F | D | 561 | $247.83 | 4,731.09 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-02-01 | M | D | 1,828 | $0.00 | 3,657 | D | $0.00 · — to 2026-02-01 | 1,828 Common Stock | (F1) This award was granted to the reporting person on February 1, 2023 and will vest in three equal installments on each anniversary of the grant date. |